ZP-049

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameZP-049
Drug Alias NameZP-049
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectantsMusculoskeletal system modulators
TargetsUpdating
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZambon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZambon
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksN/A